The Dublin-based corporate financiers plan to target acquisitions in the medical technology sector valued at €5 million to €20 million.
Harry Keenan, previously general manager of UK and Ireland at Baxter International, and Joey Mason, a former partner at Delta Partners who has previously worked in finance and business development with Morgan Stanley and Biotrin, are both working on the new project.
Dave Shanahan, former managing director of Pfizer Healthcare Ireland and head of life...
Subscribe from just €1 for the first month!
All Digital Access + eReader
Unlimited Access for 1 Month
Then €19.99 a month after the offer period.
€149 For the 1st Year
Unlimited Access for 1 Year
90 Day Pass
Get a Business Account for you and your team